{"id":13862,"date":"2025-11-28T09:07:29","date_gmt":"2025-11-28T09:07:29","guid":{"rendered":"https:\/\/mecfs-research.org\/?p=13862"},"modified":"2026-02-06T16:45:29","modified_gmt":"2026-02-06T16:45:29","slug":"fundingstrategy2026","status":"publish","type":"post","link":"https:\/\/mecfs-research.org\/en\/fundingstrategy2026\/","title":{"rendered":"Update: research funding strategy 2026 of the ME\/CFS Research Foundation"},"content":{"rendered":"<p><strong><strong><strong>Funding biomedical research on ME\/CFS and Long COVID has been the stated goal of the ME\/CFS Research Foundation since its founding four years ago. With our updated funding strategy for 2026, we are solidifying our commitment to better diagnostics and potential treatment options.&nbsp;<\/strong><\/strong><\/strong><\/p>\n\n\n\n<p>The&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/fundingstrategy2023\/\"><span style=\"text-decoration: underline;\">funding strategy to-date<\/span><\/a>, that we have been implementing since August 2023 has focused on maintaining and expanding the ME\/CFS research networks in Germany that have been established since 2022. The priorities set at that time have provided important support and new impetus for the ME\/CFS and Long COVID research that is currently being developed.<\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"Update: research funding strategy 2026 of the ME\/CFS Research Foundation\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/DzYIlIsKhmc?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><figcaption class=\"wp-element-caption\">Joerg Heydecke on the ME\/CFS Research Foundation's 2026 funding strategy <\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading\">Review of our priorities and activities in recent years:&nbsp;<\/h4>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Networking among researchers<\/strong>: the&nbsp;<a href=\"https:\/\/events.mecfs-research.org\/en\/events\/conference_2025\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">International ME\/CFS Conference<\/span><\/a>&nbsp;in Berlin in May has established itself as an important networking meeting for leading researchers worldwide. In May 2025, the&nbsp;<a href=\"https:\/\/events.mecfs-research.org\/en\/events\/conference_2025\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">International Declaration in Support of Research and Drug Development for ME\/CFS and Long COVID<\/span><\/a>&nbsp;was initiated there, among other things. In addition, with the&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/mrr\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">ME\/CFS Research Register<\/span><\/a>&nbsp;, we provide an up-to-date overview of ME\/CFS research in six countries to date as an additional information and networking tool for researchers and other interest groups.<\/li>\n\n\n\n<li><strong>Preservation of central research networks and structures created since 2022\/23<\/strong>: Project funding at the&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/mcfc-projects-2025\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">Munich Chronic Fatigue Centre for Young People (MCFC)<\/span><\/a>&nbsp;was able to preserve fundamental research infrastructure on a transitional basis at a time when its continued public funding was not yet guaranteed.<\/li>\n\n\n\n<li><strong>Expansion to include new topics and funding for individual projects<\/strong>: Both the research project on ME\/CFS biomarkers and disease mechanisms funded at&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/researchfunding-charite\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">Charit\u00e9 &#8211; Universit\u00e4tsmedizin Berlin<\/span><\/a>&nbsp;and the co-funding of the&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/researchfunding-munich\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">MCFC's model station for severely affected children and adolescents<\/span><\/a>&nbsp;have addressed this goal. We will report shortly on further funding projects already underway at Charit\u00e9 - Universit\u00e4tsmedizin Berlin.<\/li>\n\n\n\n<li><strong>Expansion of fundraising and promotion of project initiatives in other EU countries<\/strong>: We have recently been able to successfully expand our fundraising activities (see&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/2025summer-report\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">half year report summer 2025<\/span><\/a>). The expansion of our project funding to other EU countries has not yet been implemented. Unfortunately, important prerequisites for this \u2013 a sustainable assumption of funding responsibility in Germany by politicians, established funding institutions and the pharmaceutical industry \u2013 have not yet been met.&nbsp;<\/li>\n<\/ol>\n\n\n\n<p>In addition to our existing funding projects, we have been able to build up a fact-based information service with the&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/mrr\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">ME\/CFS Research Register<\/span><\/a>, the&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/researchupdate\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">ME\/CFS Research Update<\/span><\/a>&nbsp;&nbsp;(also for&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/mrr-update-dec24\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">the Netherlands\/Switzerland<\/span><\/a>&nbsp;and most recently&nbsp;<a href=\"https:\/\/mecfs-research.org\/en\/news-mrr-norway-iceland\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">Norway\/Iceland<\/span><\/a>) and the&nbsp;<span style=\"text-decoration: underline;\"><a href=\"https:\/\/mecfs-research.org\/en\/costreport\/\" target=\"_blank\" rel=\"noreferrer noopener\">study on the prevalence and costs of Long COVID and ME\/CFS<\/a><\/span>&nbsp;, which is increasingly being used by the press, other organisations and politicians.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Change in the research landscape through the \"National Decade Against Post-Infectious Diseases\"<\/h4>\n\n\n\n<p>The recently announced&nbsp;<span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.bmftr.bund.de\/SharedDocs\/Pressemitteilungen\/DE\/2025\/11\/121125-ME-CFS.html\" target=\"_blank\" rel=\"noreferrer noopener\">National Decade Against Post-Infectious Diseases<\/a><\/span>&nbsp;National Decade Against Post-Infectious Diseases (external link) opens up great opportunities for ME\/CFS and Long COVID research and will hopefully finally enable sustainable funding for comprehensive research structures. However, the first projects funded by the Decade will not start until the end of 2026 at the earliest (with results tob e expected 1-2 years later). Before the announced funding can be awarded (\u20ac50 million per year from 2026 to 2036), funding criteria must first be defined, award procedures established, application phases for researchers set up and coordinating structures for the decade programme created.<\/p>\n\n\n\n<p>The year 2026 represents a kind of \"transition phase\" for ME\/CFS research funding in Germany and thus also for the more than 1.5 million people affected and their families. In order to enable new projects during this phase, the ME\/CFS Research Foundation will announce a new funding programme in the first quarter of 2026. In addition, we will work constructively with patient organisations to help shape the content of the public \"decade funding\" programme.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">What are our funding priorities for the year 2026?<\/h4>\n\n\n\n<p>The defined goal for our 2026 funding programme is to promote biomedical research that will contribute significantly to improving the diagnosis and enabling disease-modifying treatment of ME\/CFS in the coming years. To this end, we will enable <strong>basic\/translational research and clinical research<\/strong>&nbsp;that addresses unexplained or insufficiently understood disease mechanisms, biomarkers and treatment options for ME\/CFS.<\/p>\n\n\n\n<p>In 2026, our research funding will support projects that, based on the latest scientific findings, address the following aspects:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Elucidation of the disease mechanisms<\/strong>, underlying central ME\/CFS symptoms, such as PEM (post-exertional malaise), pain, muscle weakness, cognitive dysfunction, circulatory disorders, sleep disorders and dysautonomia.<\/li>\n\n\n\n<li><strong>Developing reliable diagnostic, prognostic or predictive<\/strong>&nbsp;(taking into account important variables such as sex\/gender, age, duration of illness and severity). We focus on projects investigating autoimmunity, immune dysregulation, metabolic disorders, inflammation, vascular dysfunction, and nervous system dysfunction as causal factors in the development and progression of ME\/CFS.<\/li>\n\n\n\n<li><strong>Testing innovative, disease-mechanism-targeted drugs and treatment approaches<\/strong>&nbsp;for their suitability for effective and safe treatment of ME\/CFS. This includes drugs already approved for other diseases, such as CD19+ or CD20+ B-cell depletion, CD38+ plasmablast\/cell depletion, B-cell receptor signalling and granulocyte inhibition, selective B\/T-cell depletion, inhibition of plasma cell maturation and GLP-1 receptor agonists, or other promising drug candidates targeting the above-mentioned disease mechanisms.<\/li>\n<\/ol>\n\n\n\n<p>The evaluation and selection of eligible project applications under the new funding programme is based on criteria defined in close collaboration with our\u00a0<a href=\"https:\/\/mecfs-research.org\/en\/news-sab\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">Scientific Advisory Board<\/span><\/a>\u00a0. Details of the evaluation process and criteria will be published in due course.<\/p>\n\n\n\n<p><em><strong>Update 6 February 2026<\/strong>: The ME\/CFS Research Foundation today is launching its Research Funding Programme 2026 (<a href=\"https:\/\/mecfs-research.org\/en\/researchfunding2026\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">link to web news<\/span><\/a> and directly <a href=\"https:\/\/funding.mecfs-research.org\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline;\">to the Research Finding Programme 2026<\/span><\/a>).<\/em><\/p>\n\n\n\n<p>At the end of 2026, we will reassess the direction of public funding under the \"National Decade\" as well as the remaining funding environment, and will align our funding strategy for 2027 and beyond.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">What role will the ME\/CFS Research Foundation play in the future?<\/h4>\n\n\n\n<p>We also intend to further expand the foundation's other areas of work wherever possible. Overall, we are active in the following areas:&nbsp;<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Research funding (see the above priorities for 2026)<\/li>\n\n\n\n<li>Research networking (e.g. International ME\/CFS Conference 2026, ME\/CFS Research Register)<\/li>\n\n\n\n<li>Making research progress transparent&nbsp;<\/li>\n\n\n\n<li>Providing facts and resources for education and information<\/li>\n\n\n\n<li>Fundraising and awareness (as the basis of our work)<\/li>\n<\/ol>\n\n\n\n<p>Researchers from our network, the patient organisations, and we ourselves are convinced that strong private partners such as the ME\/CFS Research Foundation are still needed in the field of ME\/CFS research funding in order to provide the right impetus in the critical \"transition phase\" that is now beginning, with a view to ensuring that the \"National Decade\" is focused in terms of content and strategy. We are aware of this role and are doing everything we can to live up to our increased responsibility.<\/p>\n\n\n\n<p>For our future commitment, we continue to hope for the strong support of patients, their families and, increasingly, the wider public!&nbsp;<\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading\">How can you support the work of the ME\/CFS Research Foundation?<\/h4>\n\n\n\n<p>While progress has been made, there is still a long way to go before diagnosis, care and treatment of ME\/CFS patients will one day become an established medical and social standard. We at the ME\/CFS Research Foundation are focussing on biomedical research, which we see as a key element in solving these problems (more on this in <span style=\"text-decoration: underline;\"><a href=\"https:\/\/mecfs-research.org\/en\/fundingstrategy\/\" target=\"_blank\" rel=\"noreferrer noopener\">our research funding strategy<\/a><\/span> and in the recent <span style=\"text-decoration: underline;\"><a href=\"https:\/\/mecfs-research.org\/en\/reporting\/\" target=\"_blank\" rel=\"noreferrer noopener\">half year report<\/a><\/span>, which summarises our activities). To achieve this, we rely on broad support from private donors \u2013 those affected, relatives, families, friends, associations, schools, networks, companies, initiatives, event organisers and all supporters. If you are not able to provide direct support, you can share our stories and motivate others to help. Because only together can we achieve. this goal.<\/p>\n\n\n\n<p>We fully translate donations and other support into scientifically excellent research, networking and ultimately visible successes, i.e. improved ME\/CFS diagnostics and therapies. We are happy to work together with other organisations and initiatives - please contact us!<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>We appreciate all kinds of<strong> support:<\/strong><\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/mecfs-research.org\/en\/spenden\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Donate to ME\/CFS research<\/strong><\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>Please subscribe to our <strong>newsletter:<\/strong><\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/mecfs-research.org\/en\/newsletter\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Subscribe to newsletter<\/strong><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>And please help us expand our reach by<strong> following us on social media<\/strong>:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-social-links has-normal-icon-size has-visible-labels is-style-logos-only is-layout-flex wp-block-social-links-is-layout-flex\"><li class=\"wp-social-link wp-social-link-instagram  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.instagram.com\/mecfs_research\/\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewbox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M12,4.622c2.403,0,2.688,0.009,3.637,0.052c0.877,0.04,1.354,0.187,1.671,0.31c0.42,0.163,0.72,0.358,1.035,0.673 c0.315,0.315,0.51,0.615,0.673,1.035c0.123,0.317,0.27,0.794,0.31,1.671c0.043,0.949,0.052,1.234,0.052,3.637 s-0.009,2.688-0.052,3.637c-0.04,0.877-0.187,1.354-0.31,1.671c-0.163,0.42-0.358,0.72-0.673,1.035 c-0.315,0.315-0.615,0.51-1.035,0.673c-0.317,0.123-0.794,0.27-1.671,0.31c-0.949,0.043-1.233,0.052-3.637,0.052 s-2.688-0.009-3.637-0.052c-0.877-0.04-1.354-0.187-1.671-0.31c-0.42-0.163-0.72-0.358-1.035-0.673 c-0.315-0.315-0.51-0.615-0.673-1.035c-0.123-0.317-0.27-0.794-0.31-1.671C4.631,14.688,4.622,14.403,4.622,12 s0.009-2.688,0.052-3.637c0.04-0.877,0.187-1.354,0.31-1.671c0.163-0.42,0.358-0.72,0.673-1.035 c0.315-0.315,0.615-0.51,1.035-0.673c0.317-0.123,0.794-0.27,1.671-0.31C9.312,4.631,9.597,4.622,12,4.622 M12,3 C9.556,3,9.249,3.01,8.289,3.054C7.331,3.098,6.677,3.25,6.105,3.472C5.513,3.702,5.011,4.01,4.511,4.511 c-0.5,0.5-0.808,1.002-1.038,1.594C3.25,6.677,3.098,7.331,3.054,8.289C3.01,9.249,3,9.556,3,12c0,2.444,0.01,2.751,0.054,3.711 c0.044,0.958,0.196,1.612,0.418,2.185c0.23,0.592,0.538,1.094,1.038,1.594c0.5,0.5,1.002,0.808,1.594,1.038 c0.572,0.222,1.227,0.375,2.185,0.418C9.249,20.99,9.556,21,12,21s2.751-0.01,3.711-0.054c0.958-0.044,1.612-0.196,2.185-0.418 c0.592-0.23,1.094-0.538,1.594-1.038c0.5-0.5,0.808-1.002,1.038-1.594c0.222-0.572,0.375-1.227,0.418-2.185 C20.99,14.751,21,14.444,21,12s-0.01-2.751-0.054-3.711c-0.044-0.958-0.196-1.612-0.418-2.185c-0.23-0.592-0.538-1.094-1.038-1.594 c-0.5-0.5-1.002-0.808-1.594-1.038c-0.572-0.222-1.227-0.375-2.185-0.418C14.751,3.01,14.444,3,12,3L12,3z M12,7.378 c-2.552,0-4.622,2.069-4.622,4.622S9.448,16.622,12,16.622s4.622-2.069,4.622-4.622S14.552,7.378,12,7.378z M12,15 c-1.657,0-3-1.343-3-3s1.343-3,3-3s3,1.343,3,3S13.657,15,12,15z M16.804,6.116c-0.596,0-1.08,0.484-1.08,1.08 s0.484,1.08,1.08,1.08c0.596,0,1.08-0.484,1.08-1.08S17.401,6.116,16.804,6.116z\"><\/path><\/svg><span class=\"wp-block-social-link-label\">Instagram<\/span><\/a><\/li>\n\n<li class=\"wp-social-link wp-social-link-facebook  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.facebook.com\/profile.php?id=100092535845334\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewbox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M12 2C6.5 2 2 6.5 2 12c0 5 3.7 9.1 8.4 9.9v-7H7.9V12h2.5V9.8c0-2.5 1.5-3.9 3.8-3.9 1.1 0 2.2.2 2.2.2v2.5h-1.3c-1.2 0-1.6.8-1.6 1.6V12h2.8l-.4 2.9h-2.3v7C18.3 21.1 22 17 22 12c0-5.5-4.5-10-10-10z\"><\/path><\/svg><span class=\"wp-block-social-link-label\">Facebook<\/span><\/a><\/li>\n\n<li class=\"wp-social-link wp-social-link-linkedin  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.linkedin.com\/company\/mecfs-research-foundation\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewbox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M19.7,3H4.3C3.582,3,3,3.582,3,4.3v15.4C3,20.418,3.582,21,4.3,21h15.4c0.718,0,1.3-0.582,1.3-1.3V4.3 C21,3.582,20.418,3,19.7,3z M8.339,18.338H5.667v-8.59h2.672V18.338z M7.004,8.574c-0.857,0-1.549-0.694-1.549-1.548 c0-0.855,0.691-1.548,1.549-1.548c0.854,0,1.547,0.694,1.547,1.548C8.551,7.881,7.858,8.574,7.004,8.574z M18.339,18.338h-2.669 v-4.177c0-0.996-0.017-2.278-1.387-2.278c-1.389,0-1.601,1.086-1.601,2.206v4.249h-2.667v-8.59h2.559v1.174h0.037 c0.356-0.675,1.227-1.387,2.526-1.387c2.703,0,3.203,1.779,3.203,4.092V18.338z\"><\/path><\/svg><span class=\"wp-block-social-link-label\">LinkedIn<\/span><\/a><\/li>\n\n<li class=\"wp-social-link wp-social-link-x  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/twitter.com\/MECFSResearch\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewbox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M13.982 10.622 20.54 3h-1.554l-5.693 6.618L8.745 3H3.5l6.876 10.007L3.5 21h1.554l6.012-6.989L15.868 21h5.245l-7.131-10.378Zm-2.128 2.474-.697-.997-5.543-7.93H8l4.474 6.4.697.996 5.815 8.318h-2.387l-4.745-6.787Z\" \/><\/svg><span class=\"wp-block-social-link-label\">X<\/span><\/a><\/li>\n\n<li class=\"wp-social-link wp-social-link-threads  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.threads.net\/@mecfs_research\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewbox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M16.3 11.3c-.1 0-.2-.1-.2-.1-.1-2.6-1.5-4-3.9-4-1.4 0-2.6.6-3.3 1.7l1.3.9c.5-.8 1.4-1 2-1 .8 0 1.4.2 1.7.7.3.3.5.8.5 1.3-.7-.1-1.4-.2-2.2-.1-2.2.1-3.7 1.4-3.6 3.2 0 .9.5 1.7 1.3 2.2.7.4 1.5.6 2.4.6 1.2-.1 2.1-.5 2.7-1.3.5-.6.8-1.4.9-2.4.6.3 1 .8 1.2 1.3.4.9.4 2.4-.8 3.6-1.1 1.1-2.3 1.5-4.3 1.5-2.1 0-3.8-.7-4.8-2S5.7 14.3 5.7 12c0-2.3.5-4.1 1.5-5.4 1.1-1.3 2.7-2 4.8-2 2.2 0 3.8.7 4.9 2 .5.7.9 1.5 1.2 2.5l1.5-.4c-.3-1.2-.8-2.2-1.5-3.1-1.3-1.7-3.3-2.6-6-2.6-2.6 0-4.7.9-6 2.6C4.9 7.2 4.3 9.3 4.3 12s.6 4.8 1.9 6.4c1.4 1.7 3.4 2.6 6 2.6 2.3 0 4-.6 5.3-2 1.8-1.8 1.7-4 1.1-5.4-.4-.9-1.2-1.7-2.3-2.3zm-4 3.8c-1 .1-2-.4-2-1.3 0-.7.5-1.5 2.1-1.6h.5c.6 0 1.1.1 1.6.2-.2 2.3-1.3 2.7-2.2 2.7z\"\/><\/svg><span class=\"wp-block-social-link-label\">Threads<\/span><\/a><\/li>\n\n<li class=\"wp-social-link wp-social-link-youtube  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.youtube.com\/@MECFSResearchFoundation\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewbox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M21.8,8.001c0,0-0.195-1.378-0.795-1.985c-0.76-0.797-1.613-0.801-2.004-0.847c-2.799-0.202-6.997-0.202-6.997-0.202 h-0.009c0,0-4.198,0-6.997,0.202C4.608,5.216,3.756,5.22,2.995,6.016C2.395,6.623,2.2,8.001,2.2,8.001S2,9.62,2,11.238v1.517 c0,1.618,0.2,3.237,0.2,3.237s0.195,1.378,0.795,1.985c0.761,0.797,1.76,0.771,2.205,0.855c1.6,0.153,6.8,0.201,6.8,0.201 s4.203-0.006,7.001-0.209c0.391-0.047,1.243-0.051,2.004-0.847c0.6-0.607,0.795-1.985,0.795-1.985s0.2-1.618,0.2-3.237v-1.517 C22,9.62,21.8,8.001,21.8,8.001z M9.935,14.594l-0.001-5.62l5.404,2.82L9.935,14.594z\"><\/path><\/svg><span class=\"wp-block-social-link-label\">YouTube<\/span><\/a><\/li>\n\n<li class=\"wp-social-link wp-social-link-tiktok  wp-block-social-link\"><a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.tiktok.com\/@mecfsresearchfoundation\" class=\"wp-block-social-link-anchor\"><svg width=\"24\" height=\"24\" viewbox=\"0 0 32 32\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M16.708 0.027c1.745-0.027 3.48-0.011 5.213-0.027 0.105 2.041 0.839 4.12 2.333 5.563 1.491 1.479 3.6 2.156 5.652 2.385v5.369c-1.923-0.063-3.855-0.463-5.6-1.291-0.76-0.344-1.468-0.787-2.161-1.24-0.009 3.896 0.016 7.787-0.025 11.667-0.104 1.864-0.719 3.719-1.803 5.255-1.744 2.557-4.771 4.224-7.88 4.276-1.907 0.109-3.812-0.411-5.437-1.369-2.693-1.588-4.588-4.495-4.864-7.615-0.032-0.667-0.043-1.333-0.016-1.984 0.24-2.537 1.495-4.964 3.443-6.615 2.208-1.923 5.301-2.839 8.197-2.297 0.027 1.975-0.052 3.948-0.052 5.923-1.323-0.428-2.869-0.308-4.025 0.495-0.844 0.547-1.485 1.385-1.819 2.333-0.276 0.676-0.197 1.427-0.181 2.145 0.317 2.188 2.421 4.027 4.667 3.828 1.489-0.016 2.916-0.88 3.692-2.145 0.251-0.443 0.532-0.896 0.547-1.417 0.131-2.385 0.079-4.76 0.095-7.145 0.011-5.375-0.016-10.735 0.025-16.093z\" \/><\/svg><span class=\"wp-block-social-link-label\">TikTok<\/span><\/a><\/li><\/ul>\n<\/div>\n<\/div>\n\n\n\n<p><strong>Thank you for your support! <\/strong><\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Die F\u00f6rderung biomedizinischer Forschung zu ME\/CFS und Long COVID ist das erkl\u00e4rte Ziel der ME\/CFS Research Foundation seit der Gr\u00fcndung vor vier Jahren. Mit unserer aktualisierten F\u00f6rderstrategie f\u00fcr das Jahr 2026 konkretisieren wir unser Engagement f\u00fcr bessere Diagnostik und potenzielle Therapieoptionen.&nbsp; Im Fokus der&nbsp;bisherigen F\u00f6rderstrategie, die wir seit August 2023 umsetzen, stand der Erhalt und [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":15021,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1,27],"tags":[],"class_list":["post-13862","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsletter","category-projects"],"acf":[],"_links":{"self":[{"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/posts\/13862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/comments?post=13862"}],"version-history":[{"count":30,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/posts\/13862\/revisions"}],"predecessor-version":[{"id":16161,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/posts\/13862\/revisions\/16161"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/media\/15021"}],"wp:attachment":[{"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/media?parent=13862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/categories?post=13862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/tags?post=13862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}